- Conditions
- Nonsquamous Non-small Cell Lung Cancer, Parkinson Disease 4, Autosomal Dominant Lewy Body
- Locations
-
- El Camino Hospital Cancer Center ( Site 0529) Mountain View, California, United States
- Yale University ( Site 0519) New Haven, Connecticut, United States
- Holy Cross Hospital ( Site 0512) Fort Lauderdale, Florida, United States
- Mercy Health-Paducah Medical Oncology and Hematology ( Site 0570) Paducah, Kentucky, United States
Clinical trial condition
Nonsquamous Non-small Cell Lung Cancer
Explore clinical trials studying Nonsquamous Non-small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.
3 public trials
0 recruiting studies
Nonsquamous Non-small Cell Lung Cancer trial results
- Conditions
- Nonsquamous Non-small Cell Lung Cancer, Parkinson Disease 4, Autosomal Dominant Lewy Body
- Locations
-
- Peking Union Medical College Hospital ( Site 0108) Beijing, Beijing Municipality, China
- Cancer Hospital Chinese Academy of Medical Science ( Site 0117) Beijing, Beijing Municipality, China
- Beijing Cancer Hospital ( Site 0120) Beijing, Beijing Municipality, China
- The Second Hospital Affiliated to AMU ( Site 0119) Chongqing, Chongqing Municipality, China
Active, Not Recruiting
HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI Therapy
NCT05338970
- Conditions
- EGFR Exon 19 Deletion, EGFR L858R, Nonsquamous Non-small Cell Lung Cancer
- Locations
-
- Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
- Highlands Oncology Springdale, Arkansas, United States
- City of Hope Duarte, California, United States
- Moores Cancer Center at the UC San Diego Health La Jolla, California, United States